Volume 22 Number 8
August 2020

Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 8, August


Central nervous system tumors


High-grade gliomas

Low-grade gliomas

Gliomatosis cerebri

Diffuse astrocytic and oligodendroglial tumors


○○ Giant cell glioblastoma

Diffuse Midline Glioma

Ependymal tumors



Embryonal tumors




Metastatic tumors

Central nervous system tumors

Birski M, Furtak J, Krystkiewicz K, Birska J, Zielinska K, Sokal P, Rusinek M, Paczkowski D, Szylberg L, Harat M.
Endoscopic versus stereotactic biopsies of intracranial lesions involving the ventricles.
Neurosurg Rev. 2020 Aug 21. doi: 10.1007/s10143-020-01371-7. Retrospective study. _

Harrup R, White VM, Coory M, Walker R, Anazodo A, Skaczkowski G, Bibby H, Osborn M, Phillips MB, Conyers R, Thompson K, Orme LM, Pinkerton R, Nicholls W.
Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study.
J Adolesc Young Adult Oncol. 2020 Aug 26. doi: 10.1089/jayao.2020.0074. Retrospective study. _

Kojimahara N, Yoshitake T, Ono K, Kai M, Bynes G, Schüz J, Cardis E, Kesminiene A.
Computed tomography of the head and the risk of brain tumours during childhood and adolescence: results from a case-control study in Japan.
J Radiol Prot. 2020 Aug 6. doi: 10.1088/1361-6498/abacff. Case-control study. _

Kwinta BM, Myszka AM, Bigaj MM, Krzyżewski RM, Starowicz-Filip A.
Intra- and postoperative adverse events in awake craniotomy for intrinsic supratentorial brain tumors.
Neurol Sci. 2020 Aug 17. doi: 10.1007/s10072-020-04683-0. Retrospective study. _

Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P.
Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients.
Childs Nerv Syst. 2020 Aug 19. doi: 10.1007/s00381-020-04859-1. Retrospective study. _

Özütemiz C, Neil EC, Tanwar M, Rubin NT, Ozturk K, Cayci Z.
The Role of Dual-Phase FDG PET/CT in the Diagnosis and Follow-Up of Brain Tumors.
AJR Am J Roentgenol. 2020 Aug 25. 2020:1-12. doi: 10.2214/AJR.19.22571. Retrospective study. _

Ogawa T, Sawada N, Iwasaki M, Budhathoki S, Yamaji T, Shimazu T, Narita Y, Tsugane S; Japan Public Health Center-based Prospective Study Group.
Body mass index and height in relation to brain tumor risk in a Japanese population.
Ann Epidemiol. 2020 Aug 18. 2020:S1047-2797(20)30198-8. doi: 10.1016/j.annepidem.2020.06.001. Prospective study. _

Oprandi MC, Bardoni A, Massimino M, Gandola L, Poggi G.
Early neuropsychological profile of children diagnosed with a brain tumor predicts later academic difficulties at school age.
Childs Nerv Syst. 2020 Aug 4. doi: 10.1007/s00381-020-04847-5. Retrospective study. _

Renzi S, Michaeli O, Ramaswamy V, Huang A, Stephens D, Maguire B, Tabori U, Bouffet E, Bartels U.
Causes of death in pediatric neuro-oncology: the sickkids experience from 2000 to 2017.
J Neurooncol. 2020 Aug 14. 2020;149(1):181-189. doi: 10.1007/s11060-020-03590-w. Retrospective study. _

Shah AS, Yahanda AT, Sylvester PT, Evans J, Dunn GP, Jensen RL, Honeycutt J, Cahill DP, Sutherland GR, Oswood M, Shah M, Abram SR, Rich KM, Dowling JL, Leuthardt EC, Dacey RG, Kim AH, Zipfel GJ, Limbrick DD, Smyth MD, Leonard J, Chicoine MR.
Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter Study.
Neurosurgery. 2020 Aug 17. 2020;nyaa338. doi: 10.1093/neuros/nyaa338: Retrospective study. _ _


Khan I, Hatiboglu MA.
Can COVID-19 induce glioma tumorogenesis through binding cell receptors?
Med Hypotheses. 2020 Jun 19. 2020;144:110009. doi: 10.1016/j.mehy.2020.110009. In vitro/in vivo study. _

Lin Z, Yang R, Li K, Yi G, Li Z, Guo J, Zhang Z, Junxiang P, Liu Y, Qi S, Huang G.
Establishment of age group classification for risk stratification in glioma patients.
BMC Neurol. 2020 Aug 20. 2020;20(1):310. doi: 10.1186/s12883-020-01888-w. Retrospective study. _

Liu Y, Hu G, Yu Y, Jiang Z, Yang K, Hu X, Li Z, Liu D, Zou Y, Liu H, Chen J.
Structural and Functional Reorganization Within Cognitive Control Network Associated With Protection of Executive Function in Patients With Unilateral Frontal Gliomas.
Front Oncol. 2020 May 27. 2020;10:794. doi: 10.3389/fonc.2020.00794. Clinical study. _

Luo H, Zhuang Q, Wang Y, Abudumijiti A, Shi K, Rominger A, Chen H, Yang Z, Tran V, Wu G, Li Z, Fan Z, Qi Z, Guo Y, Yu J, Shi Z.
A novel image signature-based radiomics method to achieve precise diagnosis and prognostic stratification of gliomas.
In vitro Invest. 2020 Aug 22. doi: 10.1038/s41374-020-0472-x. Retrospective study. _

Oldrini B, Vaquero-Siguero N, Mu Q, Kroon P, Zhang Y, Galán-Ganga M, Bao Z, Wang Z, Liu H, Sa JK, Zhao J, Kim H, Rodriguez-Perales S, Nam DH, Verhaak RGW, Rabadan R, Jiang T, Wang J, Squatrito M.
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.
Nat Commun. 2020 Aug 4. 2020;11(1):3883. doi: 10.1038/s41467-020-17717-0. In vitro/in vivo study. _

Pan YB, Zhu Y, Zhang QW, Zhang CH, Shao A, Zhang J.
Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis.
Front Oncol. 2020 Jul 24. 2020;10:1057. doi: 10.3389/fonc.2020.01057. Retrospective study/Nomogram. _

Raschke F, Seidlitz A, Wesemann T, Löck S, Jentsch C, Platzek I, Petr J, van den Hoff J, Kotzerke J, Beuthien-Baumann B, Baumann M, Linn J, Krause M, Troost EGC.
Dose dependent cerebellar atrophy in glioma patients after radio(chemo)therapy.
Radiother Oncol. 2020 Jul 30. 2020;150:262-267. doi: 10.1016/j.radonc.2020.07.044. Prospective study. _

Rani N, Singh B, Kumar N, Singh P, Hazari PP, Jaswal A, Gupta SK, Chhabra R, Radotra BD, Mishra AK.
The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices.
Nucl Med Commun. 2020 Sep;41(9):848-857. doi: 10.1097/MNM.0000000000001230. Prospective study. _

Taksande AM, Gandhi A, Meshram RJ, Gandhi A, Lohakare A.
Glioma Presenting as an Isolated Facial Nerve Palsy: A Case Report.
Neurol India. 2020 Aug 26. 2020;68(4):900-902. doi: 10.4103/0028-3886.293480. Case report. _

Zhang X, Li C, Xiao L, Gao C, Zhao W, Yang M, Sun T, Wang F.
Predicting Individual Prognosis and Grade of Patients with Glioma Based on Preoperative Eosinophil and Neutrophil-to-Lymphocyte Ratio.
Cancer Manag Res. 2020 Jul 14. 2020;12:5793-5802. doi: 10.2147/CMAR.S260695. Retrospective study. _

Zhou W, Zhou Z, Wen J, Xie F, Zhu Y, Zhang Z, Xiao J, Chen Y, Li M, Guan Y, Hua T.
A Nomogram Modeling 11C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation.
Front Oncol. 2020 Jul 24;10:1200. doi: 10.3389/fonc.2020.01200. Retrospective study. _

High-grade gliomas

Decavèle M, Gatulle N, Weiss N, Rivals I, Idbaih A, Demeret S, Mayaux J, Dres M, Morawiec E, Hoang-Xuan K, Similowski T, Demoule A.
One-year survival of patients with high-grade glioma discharged alive from the intensive care unit.
J Neurol. 2020 Aug 29. doi: 10.1007/s00415-020-10191-0. Retrospective study. _

Lombardi G, Barresi V, Indraccolo S, Simbolo M, Fassan M, Mandruzzato S, Simonelli M, Caccese M, Pizzi M, Fassina A, Padovan M, Masetto E, Gardiman MP, Bonavina MG, Caffo M, Persico P, Chioffi F, Denaro L, Dei Tos AP, Scarpa A, Zagonel V.
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study.
Cancers (Basel). 2020 Aug 14;12(8):E2283. doi: 10.3390/cancers12082283. Prospective study. _

Sui Z, Zhang X, Li H, Xu D, Li G.
Magnetic resonance imaging evaluation of brain glioma before postoperative radiotherapy.
Clin Transl Oncol. 2020 Aug 28. doi: 10.1007/s12094-020-02474-9. Retrospective study. _

Yang Y, Yao M, Long S, Xu C, Li L, Li Y, Li G.
Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective study. Based on the SEER Database.
Biomed Res Int. 2020 Jul 25. 2020;2020:1346340. doi: 10.1155/2020/1346340. Retrospective study. _

Yuan T, Ying J, Zuo Z, Jin L, Gui S, Gao Z, Li G, Wang R, Zhang Y, Li C.
Contrahemispheric Cortex Predicts Survival and Molecular Markers in Patients With Unilateral High-Grade Gliomas.
Front Oncol. 2020 Jul 23. 2020;10:953. doi: 10.3389/fonc.2020.00953. Observational study. _

Zheng L, Zhang M, Hou J, Gong J, Nie L, Chen X, Zhou Q, Chen N.
High-grade gliomas with isocitrate dehydrogenase wild-type and 1p/19q codeleted: Atypical molecular phenotype and current challenges in molecular diagnosis.
Neuropathology. 2020 Aug 5. doi: 10.1111/neup.12672. Case report. _

Low-grade gliomas

An Y, Wang Q, Zhang L, Sun F, Zhang G, Dong H, Li Y, Peng Y, Li H, Zhu W, Ji S, Wang Y, Guo X.
OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma.
Front Oncol. 2020 Jul 7. 2020;10:1097. doi: 10.3389/fonc.2020.01097. Online tool. _

Keshri V, Deshpande RP, Chandrasekhar YBVK, Panigrahi M, Rao IS, Babu PP.
Risk Stratification in Low Grade Glioma: A Single Institutional Experience.
Neurol India. 2020 Aug 26. 2020;68(4):803-812. doi: 10.4103/0028-3886.293441. Observational study. _

Manoharan N, Choi J, Chordas C, Zimmerman MA, Scully J, Clymer J, Filbin M, Ullrich NJ, Bandopadhayay P, Chi SN, Yeo KK.
Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma.
J Neurooncol. 2020 Aug 11. doi: 10.1007/s11060-020-03592-8. Retrospective study. _

Park CJ, Han K, Kim H, Ahn SS, Choi YS, Park YW, Chang JH, Kim SH, Jain R, Lee SK.
Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Eur Radiol. 2020 Aug 1. doi: 10.1007/s00330-020-07089-w. Retrospective study. _

Gliomatosis cerebri

Mingomataj E, Soleiman A, Sajan A, Velayudhan V.
Gliomatosis cerebri mimicking diffuse demyelinating disease: Case Report.
Radiol Case Rep. 2020 Jul 22;15(9):1683-1688. doi: 10.1016/j.radcr.2020.06.043. Case report. _

Diffuse astrocytic and oligodendroglial tumors


Altwairgi AK, Alghareeb WA, AlNajjar FH, Alhussain H, Alsaeed E, Balbaid AAO, Aldanan S, Orz Y, Alsharm AA.
Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study.
Invest New Drugs. 2020 Aug 27. doi: 10.1007/s10637-020-00992-5. Phase II study. _

Armocida D, Frati A, Salvati M, Santoro A, Pesce A.
Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.
Clin Neurol Neurosurg. 2020 Aug 3;198:106126. doi: 10.1016/j.clineuro.2020.106126; Retrospective study. _

Baid U, Rane SU, Talbar S, Gupta S, Thakur MH, Moiyadi A, Mahajan A.
Overall Survival Prediction in Glioblastoma With Radiomic Features Using Machine Learning.
Front Comput Neurosci. 2020 Aug 4. 2020;14:61. doi: 10.3389/fncom.2020.00061. Radiomic study. _

Berger K, Turowski B, Felsberg J, Malzkorn B, Reifenberger G, Steiger HJ, Budach W, Haussmann J, Knipps J, Rapp M, Hänggi D, Sabel M, Mijderwijk HJ, Kamp MA.
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.
J Cancer Res Clin Oncol. 2020 Aug 3. doi: 10.1007/s00432-020-03334-3. Retrospective study. _

Briones-Claudett KH, Briones-Claudett MH, Villacrés Garcia F, Ortega Almeida C, Escudero-Requena A, Benítez Solís J, Briones Zamora KH, Briones Márquez DC, Grunauer M.
Early Pulmonary Metastasis After a Surgical Resection of Glioblastoma Multiforme. A Case Report.
Am J Case Rep. 2020 Jun 9. 2020;21:e922976. doi: 10.12659/AJCR.922976?. Case report. _

Compter I, Eekers DBP, Hoeben A, Rouschop KMA, Reymen B, Ackermans L, Beckervordersantforth J, Bauer NJC, Anten MM, Wesseling P, Postma AA, De Ruysscher D, Lambin P.
Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.
Autophagy. 2020 Aug 31. doi: 10.1080/15548627.2020.1816343; Phase IB study. _

Fu W, Wang W, Li H, Jiao Y, Huo R, Yan Z, Wang J, Wang S, Wang J, Chen D, Cao Y, Zhao J.
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
Front Immunol. 2020 May 7. 2020;11:835. doi: 10.3389/fimmu.2020.00835. In vitro/in vivo study. _

Grimes DR, Jansen M, Macauley RJ, Scott JG, Basanta D.
Evidence for hypoxia increasing the tempo of evolution in glioblastoma.
Br J Cancer. 2020 Aug 27. doi: 10.1038/s41416-020-1021-5. In vitro/in vivo study. _

Hung HC, Liu CC, Chuang JY, Su CL, Gean PW.
Inhibition of Sonic Hedgehog Signaling Suppresses Glioma Stem-Like Cells Likely Through Inducing Autophagic Cell Death.
Front Oncol. 2020 Jul 24. 2020;10:1233. doi: 10.3389/fonc.2020.01233. In vitro/in vivo study. _

Incekara F, Smits M, van der Voort SR, Dubbink HJ, Atmodimedjo PN, Kros JM, Vincent AJPE, van den Bent M.
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma.
Front Oncol. 2020 Jul 10. 2020;10:1087. doi: 10.3389/fonc.2020.01087. Retrospective study. _

Kong Y, Feng ZC, Zhang YL, Liu XF, Ma Y, Zhao ZM, Huang B, Chen AJ, Zhang D, Thorsen F, Wang J, Yang N, Li XG.
Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Front Immunol. 2020 Jul 16. 2020;11:1281. doi: 10.3389/fimmu.2020.01281. In vitro/in vivo study. _

Krawczynski K, Godlewski J, Bronisz A.
Oxidative Stress-Part of the Solution or Part of the Problem in the Hypoxic Environment of a Brain Tumor.
Antioxidants (Basel). 2020 Aug 14. 2020;9(8):E747. doi: 10.3390/antiox9080747. In vitro/in vivo study. _

Mitchell D, Dey M.
Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma.
Transl Cancer Res. 2019 Dec;8(Suppl 6):S577-S579. Doi: 10.21037/tcr.2019.05.24. Comment. _
Refers to: Cloughesy TF, et al., Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med. 2019 Feb 11. 2019;25(3):477-486. doi: 10.1038/s41591-018-0337-7. Clinical study. _

Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, McGovern SL, Grassberger C, Shih H, Ellsworth S, Grosshans DR.
Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons.
Neuro Oncol. 2020 Aug 5. 2020;noaa182. doi: 10.1093/neuonc/noaa182. Phase II study. _

Neth BJ, Ruff MW, Uhm JH, Johnson DR, Divekar RD, Maddox DE.
Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity.
Cancer Chemother Pharmacol. 2020 Aug 10. doi: 10.1007/s00280-020-04123-y. Retrospective study. _

Palpan Flores A, Vivancos Sanchez C, Roda JM, Cerdán S, Barrios AJ, Utrilla C, Royo A, Gandía González ML.
Assessment of Pre-operative Measurements of Tumor Size by MRI Methods as Survival Predictors in Wild Type IDH Glioblastoma.
Front Oncol. 2020 Sep 2. doi: 10.3389/fonc.2020.01662. Pilot study. _

Sánchez-Ortega JF, Aguas-Valiente J, Sota-Ochoa P, Calatayud-Pérez J.
Glioblastoma with primitive neuronal component: A case report and considerations of fluorescence-guided surgery.
Surg Neurol Int. 2020 Jul 4. 2020;11:178. doi: 10.25259/SNI_272_2020. Case report. _

Sibanda Z, Farahani N, Ogbonnaya E, Albanese E.
Glioblastoma Multiforme: A rare case of Spinal drop metastasis.
World Neurosurg. 2020 Aug 18. 2020;S1878-8750(20)31853-2. doi: 10.1016/j.wneu.2020.08.086; Case report. _

Smith C, Lineburg KE, Martins JP, Ambalathingal G, Neller MA, Morrison B, Matthews KK, Rehan S, Crooks P, Panikkar A, Beagley L, Le Texier L, Srihari S, Walker D, Khanna R.
Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme.
J Clin Invest. 2020 Aug 11. 2020;138649. doi: 10.1172/JCI138649. Prospective study. _

Sokmen FC, Karacin C.
Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme.
J Coll Physicians Surg Pak. 2020 Jul;30(7):713-716. doi: 10.29271/jcpsp.2020.07.713. Retrospective study. _

Sperry J, Condro MC, Guo L, Braas D, Vanderveer-Harris N, Kim KKO, Pope WB, Divakaruni AS, Lai A, Christofk H, Castro MG, Lowenstein PR, Le Belle JE, Kornblum HI.
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy.
iScience. 2020 Aug 13. 2020;23(9):101453. doi: 10.1016/j.isci.2020.101453. In vitro/in vivo study. _

Suter Y, Knecht U, Alão M, Valenzuela W, Hewer E, Schucht P, Wiest R, Reyes M.
Radiomics for glioblastoma survival analysis in pre-operative MRI: exploring feature robustness, class boundaries, and machine learning techniques.
Cancer Imaging. 2020 Aug 5. 2020;20(1):55. doi: 10.1186/s40644-020-00329-8. Retrospective study. _

Wang S, He Q, Zhang Q, Guan B, Zhou X.
Clinicopathologic features and prognosis of epithelioid glioblastoma.
Int J Clin Exp Pathol. 2020 Jul 1. 2020;13(7):1529-1539. PMCID: PMC7414508. Retrospective study. _

Xia W, Hu B, Li H, Geng C, Wu Q, Yang L, Yin B, Gao X, Li Y, Geng D.
Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
J Magn Reson Imaging. 2020 Aug 31. doi: 10.1002/jmri.27344. Retrospective study. _

Yoon HG, Cheon W, Jeong SW, Kim HS, Kim K, Nam H, Han Y, Lim DH.
Multi-Parametric Deep Learning Model for Prediction of Overall Survival after Postoperative Concurrent Chemoradiotherapy in Glioblastoma Patients.
Cancers (Basel). 2020 Aug 14. 2020;12(8):E2284. doi: 10.3390/cancers12082284. Retrospective study. _

Zeng A, Wei Z, Rabinovsky R, Jun HJ, El Fatimy R, Deforzh E, Arora R, Yao Y, Yao S, Yan W, Uhlmann EJ, Charest A, You Y, Krichevsky AM.
Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism.
iScience. 2020 Jul 28. 2020;23(8):101420. doi: 10.1016/j.isci.2020.101420. In vitro/in vivo study. _

Zhu J, Teolis S, Biassou N, Tabb A, Jabin PE, Lavi O.
Tracking the adaptation and compensation processes of patients brain arterial network to an evolving glioblastoma.
IEEE Trans Pattern Anal Mach Intell. 2020 Jul 9. doi: 10.1109/TPAMI.2020.3008379. Artificial intelligence project. _

Giant cell glioblastoma

Reddy SV, Kaiser AE, Liuzzi FJ.
Characterization and Histological Examination of a Rare Giant Cell Glioblastoma.
Cureus. 2020 Jul 17. 2020;12(7):e9237. doi: 10.7759/cureus.9237. Case report. _

Diffuse midline glioma

Vitanza NA, Khalatbari H, Ermoian R, Sarthy J, Lockwood CM, Cole BL, Leary SES.
Molecularly Targeted Treatments for NF1-Mutant Diffuse Intrinsic Pontine Glioma.
J Appl In vitro Med. 2020 Aug 30. 2020;jfaa086. doi: 10.1093/jalm/jfaa086. Case report. _

Zanazzi G, Liechty BL, Pendrick D, Krasnozhen-Ratush O, Snuderl M, Allen JC, Garvin JH, Mansukhani MM, Roth KA, Hsiao SJ.
Diffuse midline glioma with novel, potentially targetable, FGFR2-VPS35 fusion.
Cold Spring Harb Mol Case Stud. 2020 Aug 24. 2020;mcs.a005660. doi: 10.1101/mcs.a005660. Case report. _

Ependymal tumors


Go KO, Lee M, Lim Y, Lee KS, Choe G, Kim CY.
A rare case of intraparenchymal subependymoma in a child.
Childs Nerv Syst. 2020 Aug 17. doi: 10.1007/s00381-020-04862-6. Case report. _


Gillen AE, Riemondy KA, Amani V, Griesinger AM, Gilani A, Venkataraman S, Madhavan K, Prince E, Sanford B, Hankinson TC, Handler MH, Vibhakar R, Jones KL, Mitra S, Hesselberth JR, Foreman NK, Donson AM.
Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology.
Cell Rep. 2020 Aug 11. 2020;32(6):108023. doi: 10.1016/j.celrep.2020.108023. In vitro/in vivo study. _

Embryonal tumors


Chen X, Fan Z, Li KK, Wu G, Yang Z, Gao X, Liu Y, Wu H, Chen H, Tang Q, Chen L, Wang Y, Mao Y, Ng HK, Shi Z, Yu J, Zhou L.
Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study.
Neurooncol Adv. 2020 Jun 22. 2020;2(1):vdaa079. doi: 10.1093/noajnl/vdaa079. Retrospective study. _

Franceschi E, Minichillo S, Mura A, Tosoni A, Mascarin M, Tomasello C, Bartolini S, Brandes AA.
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
BMC Cancer. 2020 Aug 12. 2020;20(1):755. doi: 10.1186/s12885-020-07237-x. Retrospective study. _

Gendreau JL, Gupta S, Giles TX, Stone CE, Abraham ME, Lindley JG.
A Retrospective Analysis of the Demographics, Treatment, and Survival Outcomes of Patients with Desmoplastic Nodular Medulloblastoma Using the Surveillance, Epidemiology, and End Results (SEER) Database.
Cureus. 2020 Jul 7. 2020;12(7):e9042. doi: 10.7759/cureus.9042. Retrospective study. _

Hicks D, Rafiee G, Schwalbe EC, Howell CI, Lindsey JC, Hill RM, Smith AJ, Adidharma P, Steel C, Richardson S, Pease L, Danilenko M, Crosier S, Joshi A, Wharton SB, Jacques TS, Pizer B, Michalski A, Williamson D, Bailey S, Clifford SC.
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes.
Neuropathol Appl Neurobiol. 2020 Aug 11. doi: 10.1111/nan.12656. Retrospective study. _

Manoranjan B, Venugopal C, Bakhshinyan D, Adile AA, Richards L, Kameda-Smith MM, Whitley O, Dvorkin-Gheva A, Subapanditha M, Savage N, Tatari N, McKenna D, Bassey-Archibong B, Winegarden N, Hallett R, Provias JP, Yarascavitch B, Ajani O, Fleming A, Bader GD, Pugh TJ, Doble BW, Singh SK.
Wnt activation as a therapeutic strategy in medulloblastoma.
Nat Commun. 2020 Aug 28;11(1):4323. doi: 10.1038/s41467-020-17953-4. In vitro/in vivo study. _

Massimino M, Podda M, Gandola L, Pignoli E, Seregni E, Morosi C, Spreafico F, Ferrari A, Pecori E, Terenziani M.
Long-term results of suppressing thyroid-stimulating hormone during radiotherapy to prevent primary hypothyroidism in medulloblastoma/PNET and Hodgkin lymphoma: a prospective cohort study.
Front Med. 2020 Aug 13. doi: 10.1007/s11684-020-0752-2. Prospective study. _

Nobre L, Zapotocky M, Khan S, Fukuoka K, Fonseca A, McKeown T, Sumerauer D, Vicha A, Grajkowska WA, Trubicka J, Li KKW, Ng HK, Massimi L, Lee JY, Kim SK, Zelcer S, Vasiljevic A, Faure-Conter C, Hauser P, Lach B, van Veelen-Vincent ML, French PJ, Van Meir EG, Weiss WA, Gupta N, Pollack IF, Hamilton RL, Nageswara Rao AA, Giannini C, Rubin JB, Moore AS, Chambless LB, Vibhakar R, Ra YS, Massimino M, McLendon RE, Wheeler H, Zollo M, Ferruci V, Kumabe T, Faria CC, Sterba J, Jung S, López-Aguilar E, Mora J, Carlotti CG, Olson JM, Leary S, Cain J, Krskova L, Zamecnik J, Hawkins CE, Tabori U, Huang A, Bartels U, Northcott PA, Taylor MD, Yip S, Hansford JR, Bouffet E, Ramaswamy V.
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.
Cell Rep Med. 2020 Jun 23. 2020;1(3):100038. doi: 10.1016/j.xcrm.2020.100038. Retrospective study. _



Nassiri F, Suppiah S, Wang JZ, Badhiwala JH, Juraschka K, Meng Y, Nejad R, Au K, Willmarth NE, Cusimano M, Zadeh G.
How to live with a meningioma: experiences, symptoms, and challenges reported by patients.
Neurooncol Adv. 2020 Jul 10. 2020;2(1):vdaa086. doi: 10.1093/noajnl/vdaa086. Survey. _

Metastatic tumors

Hussein A, Rohde V, Wolfert C, Hernandez-Duran S, Fiss I, Bleckmann A, Freer AB, Mielke D, Schatlo B.
Survival after resection of brain metastases with white light microscopy versus fluorescence-guidance: A matched cohort analysis

of the Metastasys study data.
Oncotarget. 2020 Aug 11. 2020;11(32):3026-3034. doi: 10.18632/oncotarget.27688. Retrospective study. _

Soler DC, Kerstetter-Fogle A, Elder T, Raghavan A, Barnholtz-Sloan JS, Cooper KD, McCormick TS, Sloan AE.
A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.
Neurosurgery. 2020 Aug 21. 2020;nyaa334. doi: 10.1093/neuros/nyaa334. Observational cohort study. _